Letter
Clinical Neurology
Aravind Ganesh, Steven Galetta
Summary: The study shows that ChEIs have cognitive benefits for AD patients and lower mortality rates, with galantamine significantly associated with reduced risk of severe dementia. However, the causal relationship between ChEI use and reduced mortality remains uncertain, with challenges of baseline differences and potential confounding factors to consider.
Article
Medicine, General & Internal
Sarah C. M. Roberts, Claudia Zaugg, M. Antonia Biggs
Summary: A cross-sectional study found that warning signs policies mandating point-of-sale warnings about the risks of cannabis use during pregnancy did not reduce cannabis use during pregnancy. However, these policies were associated with increased support for punishment and stigma among those who did not use cannabis.
Editorial Material
Biochemistry & Molecular Biology
Thomas P. Sakmar
Summary: This study reveals that the increased cardiovascular risks associated with cannabis use are caused by proinflammatory signaling of the cannabinoid 1 (CB1) receptor, which can be alleviated by the natural antioxidant genistein.
Article
Critical Care Medicine
Robert J. Hancox, Andrew R. Gray, Xian Zhang, Richie Poulton, Terrie E. Moffitt, Avshalom Caspi, Malcolm R. Sears
Summary: This study found that cannabis use is associated with higher lung volumes and lower midexpiratory airflow, but does not cause a decrease in the FEV1/FVC ratio, which distinguishes it from tobacco use. Furthermore, the study provides evidence that lifetime cannabis use may impair gas transfer.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
(2022)
Article
Public, Environmental & Occupational Health
Jennifer A. Bailey, Stacey S. Tiberio, David C. R. Kerr, Marina Epstein, Kimberly L. Henry, Deborah M. Capaldi
Summary: Canada, Uruguay, and 18 states in the U.S. have legalized nonmedical cannabis for adults, but the impact on adolescent cannabis use remains unclear. This study found that cannabis legalization did not predict changes in adolescent cannabis use among 13-18 year olds in Oregon, New York, and Washington. Findings suggest that legalization did not affect the prevalence or frequency of adolescent cannabis use.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE
(2023)
Article
Medicine, General & Internal
Gwen T. Lapham, Theresa E. Matson, Jennifer F. Bobb, Casey Luce, Malia M. Oliver, Leah K. Hamilton, Katharine A. Bradley
Summary: The prevalence and severity of cannabis use disorders (CUD) among primary care patients in a state with legal recreational use were examined. The study found that CUD was common among cannabis users, with higher rates observed among those who reported nonmedical use. These findings highlight the importance of assessing cannabis use and CUD symptoms in medical settings.
Review
Pharmacology & Pharmacy
Shangkun Si, Xiaohu Zhao, Fan Su, Hongxiu Lu, Dongbin Zhang, Li Sun, Fulei Wang, Li Xu
Summary: This article reviews the research evidence of the regulatory effect of neostigmine on immune-inflammatory response and its impact on perioperative neurocognitive function over the past 20 years. It aims to provide new perspectives and strategies for the clinical application of neostigmine.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Multidisciplinary Sciences
Carrie Cuttler, Emily M. LaFrance, Amanda Stueber
Summary: Statewide legislation has increased access to high-potency cannabis, but federal restrictions limit access to research on low-potency whole-plant cannabis. This study examined the acute cognitive effects of high-potency cannabis, finding that high-potency flower with CBD impaired free recall, flower without CBD and concentrates affected source memory, and all three products increased susceptibility to false memories.
SCIENTIFIC REPORTS
(2021)
Article
Public, Environmental & Occupational Health
Jason R. Kilmer, Isaac C. Rhew, Katarina Guttmannova, Charles B. Fleming, Brittney A. Hultgren, Michael S. Gilson, Rachel L. Cooper, Julia Dilley, Mary E. Larimer
Summary: Prevalence of cannabis use and cannabis use disorder symptomatology among young adults in Washington State has increased since legalization, especially among those of legal age. This trend requires ongoing monitoring.
AMERICAN JOURNAL OF PUBLIC HEALTH
(2022)
Article
Geriatrics & Gerontology
Karli K. Watson, Angela D. Bryan, Rachel E. Thayer, Jarrod M. Ellingson, Carillon J. Skrzynski, Kent E. Hutchison
Summary: Research suggests that older adults have increased their cannabis use, and the effects of cannabis differ between older and younger individuals. Resting state functional connectivity (rsFC) measures show differences in brain connectivity between older adult cannabis users and non-users, as well as similarities between young non-users and older non-users. Future studies should investigate the potential risks and benefits of cannabinoids on cognition and brain health for older adults.
FRONTIERS IN AGING NEUROSCIENCE
(2022)
Article
Substance Abuse
Jarrod M. Ellingson, J. Megan Ross, Evan Winiger, Michael C. Stallings, Robin P. Corley, Naomi P. Friedman, John K. Hewitt, Susan F. Tapert, Sandra A. Brown, Tamara L. Wall, Christian J. Hopfer
Summary: Moderate adolescent cannabis use may have negative effects on cognitive functioning, specifically verbal memory, and these effects cannot be explained by familial factors.
Article
Medicine, General & Internal
Amanda Doggett, Kyla Belisario, Andre J. Mcdonald, Mark A. Ferro, James G. Murphy, James Mackillop
Summary: A longitudinal observational cohort study in Canada found that there were decreases in cannabis use frequency and related consequences among high-risk young adults after recreational cannabis legalization.
Article
Public, Environmental & Occupational Health
George Sam Wang, Christine Buttorff, Asa Wilks, Daniel Schwam, Torri D. Metz, Gregory Tung, Rosalie Liccardo Pacula
Summary: The study aimed to evaluate the association between the presence of recreational cannabis dispensaries and the prevalence of cannabis-involved pregnancy hospitalizations in Colorado. The findings showed that increasing recreational dispensaries were associated with an increase in hospitalizations, particularly in counties with no prior exposure to medical cannabis.
PREVENTIVE MEDICINE
(2022)
Article
Substance Abuse
Sameer Imtiaz, Yeshambel T. Nigatu, Farihah Ali, Laura Douglas, Hayley A. Hamilton, Jurgen Rehm, Sergio Rueda, Robert M. Schwartz, Samantha Wells, Tara Elton-Marshall
Summary: In the context of cannabis legalization in Canada, this study examined the effects on cannabis patterns of consumption, including cannabis use, daily cannabis use and cannabis-related problems. The results showed that cannabis legalization was associated with an increased likelihood of cannabis use, daily cannabis use and cannabis-related problems.
DRUG AND ALCOHOL DEPENDENCE
(2023)
Review
Pharmacology & Pharmacy
Eric Fordjour, Charles F. Manful, Albert A. Sey, Rabia Javed, Thu Huong Pham, Raymond Thomas, Mumtaz Cheema
Summary: Cannabis sativa is a versatile plant with various uses in medicine, agriculture, food, and cosmetics. It contains numerous chemical compounds, including cannabinoids and non-cannabinoids. The main active component is a cannabinoid, mostly found in the flowers, with terpenes forming the largest composition in the plant. The plant's pharmacological evidence suggests potential as antioxidants, antibacterial agents, anticancer agents, and anti-inflammatory agents, with reported applications in the food and cosmetic industries.
FRONTIERS IN PHARMACOLOGY
(2023)
Editorial Material
Psychology, Clinical
Julia D. Buckner, Michael J. Zvolensky, Norman B. Schmidt, Kathleen M. Carroll, Chris Schatschneider, Kathleen Crapanzano
ADDICTIVE BEHAVIORS
(2014)
Article
Psychology, Biological
Brian D. Kiluk, Theresa A. Babuscio, Charla Nich, Kathleen M. Carroll
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
(2013)
Article
Psychiatry
Brian D. Kiluk, Kathleen M. Carroll
CURRENT PSYCHIATRY REPORTS
(2013)
Article
Psychology, Clinical
Marci R. Mitchell, Iris M. Balodis, Elise E. DeVito, Cheryl M. Lacadie, Jon Yeston, Dustin Scheinost, R. Todd Constable, Kathleen M. Carroll, Marc N. Potenza
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
(2013)
Article
Psychology, Clinical
Leonardo F. Andrade, Kathleen M. Carroll, Nancy M. Petry
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
(2013)
Review
Substance Abuse
Mallory J. E. Loflin, Brian D. Kiluk, Marilyn A. Huestis, Will M. Aklin, Alan J. Budney, Kathleen M. Carroll, Deepak Cyril D'Souza, Robert H. Dworkin, Kevin M. Gray, Deborah S. Hasin, Dustin C. Lee, Bernard Le Foll, Frances R. Levin, Joshua A. Lile, Barbara J. Mason, Aimee L. McRae-Clark, Ivan Montoya, Erica N. Peters, Tatiana Ramey, Dennis C. Turk, Ryan Vandrey, Roger D. Weiss, Eric C. Strain
DRUG AND ALCOHOL DEPENDENCE
(2020)
Article
Substance Abuse
Corey R. Roos, Kathleen M. Carroll, Charla Nich, Tami Frankforter, Brian D. Kiluk
DRUG AND ALCOHOL DEPENDENCE
(2020)
Article
Psychology, Multidisciplinary
Kathleen M. Carroll
Summary: A single treatment approach is insufficient for the diversity of individuals with SUDs, requiring personalized interventions through multivariate phenotyping and direct targeting of core mechanisms. Technology-delivered interventions will play a crucial role in ensuring tailored and systematic treatment delivery.
CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE
(2021)
Article
Substance Abuse
Corey R. Roos, Brian D. Kiluk, R. Kathryn McHugh, Kathleen M. Carroll
PSYCHOLOGY OF ADDICTIVE BEHAVIORS
(2020)
Article
Substance Abuse
Kathleen M. Carroll, Elise E. DeVito, Sarah W. Yip, Charla Nich, Mehmet Sofuoglu
AMERICAN JOURNAL ON ADDICTIONS
(2019)
Article
Substance Abuse
Nancy M. Petry, Kathleen M. Carroll
PSYCHOLOGY OF ADDICTIVE BEHAVIORS
(2013)
Article
Substance Abuse
Brian D. Kiluk, Jessica A. Dreifuss, Roger D. Weiss, Viviana E. Horigian, Kathleen M. Carroll
PSYCHOLOGY OF ADDICTIVE BEHAVIORS
(2013)
Article
Psychology, Clinical
R. Kathryn McHugh, Elise E. DeVito, Dorian Dodd, Kathleen M. Carroll, Jennifer Sharpe Potter, Shelly E. Greenfield, Hilary Smith Connery, Roger D. Weiss
JOURNAL OF SUBSTANCE ABUSE TREATMENT
(2013)
Article
Substance Abuse
Patrick D. Worhunsky, Michael C. Stevens, Kathleen M. Carroll, Bruce J. Rounsaville, Vince D. Calhoun, Godfrey D. Pearlson, Marc N. Potenza
PSYCHOLOGY OF ADDICTIVE BEHAVIORS
(2013)
Article
Psychology, Clinical
Lisa A. Marsch, Kathleen M. Carroll, Brian D. Kiluk
JOURNAL OF SUBSTANCE ABUSE TREATMENT
(2014)